NO20070296L - Oligomere peptider og deres anvendelse for behandling av HIV infeksjoner - Google Patents

Oligomere peptider og deres anvendelse for behandling av HIV infeksjoner

Info

Publication number
NO20070296L
NO20070296L NO20070296A NO20070296A NO20070296L NO 20070296 L NO20070296 L NO 20070296L NO 20070296 A NO20070296 A NO 20070296A NO 20070296 A NO20070296 A NO 20070296A NO 20070296 L NO20070296 L NO 20070296L
Authority
NO
Norway
Prior art keywords
peptide
phenylalanine
oligomeric
oligomeric peptides
valine
Prior art date
Application number
NO20070296A
Other languages
English (en)
Norwegian (no)
Inventor
Knut Adermann
Frank Kirchhoff
Jan Muench
Axel Schulz
Wolf-Georg Forssmann
Original Assignee
Ipf Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipf Pharmaceuticals Gmbh filed Critical Ipf Pharmaceuticals Gmbh
Publication of NO20070296L publication Critical patent/NO20070296L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20070296A 2004-06-18 2007-01-16 Oligomere peptider og deres anvendelse for behandling av HIV infeksjoner NO20070296L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US58038404P 2004-06-18 2004-06-18
EP04014304 2004-06-18
US67586105P 2005-04-29 2005-04-29
PCT/EP2005/052833 WO2005123771A2 (fr) 2004-06-18 2005-06-17 Peptides oligomeres et leur utilisation pour traiter des infections a vih

Publications (1)

Publication Number Publication Date
NO20070296L true NO20070296L (no) 2007-02-27

Family

ID=34925397

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070296A NO20070296L (no) 2004-06-18 2007-01-16 Oligomere peptider og deres anvendelse for behandling av HIV infeksjoner

Country Status (13)

Country Link
US (1) US20070123465A1 (fr)
EP (1) EP1756160B1 (fr)
JP (1) JP4782782B2 (fr)
CN (1) CN100577686C (fr)
AP (1) AP2081A (fr)
AU (1) AU2005254736B2 (fr)
BR (1) BRPI0511005A (fr)
CA (1) CA2569807A1 (fr)
EA (1) EA011037B1 (fr)
MX (1) MXPA06014393A (fr)
NO (1) NO20070296L (fr)
WO (1) WO2005123771A2 (fr)
ZA (1) ZA200705769B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101489571B (zh) * 2005-11-02 2014-06-18 Ambrx公司 生物合成多肽融合抑制剂
WO2009015384A1 (fr) * 2007-07-26 2009-01-29 University Of Rochester Composés de liaison aux acides nucléiques et procédés d'utilisation
CN101993485B (zh) * 2009-08-20 2013-04-17 重庆富进生物医药有限公司 促胰岛素分泌肽类似物同源二聚体及其用途
GR1007010B (el) * 2009-10-08 2010-10-07 Χημικα Και Βιοφαρμακευτικα Εργαστηρια Πατρων Αε (Cbl-Patras), Ινσουλινοειδη πεπτιδια
CA2790343A1 (fr) * 2010-02-18 2011-08-25 Advanced Proteome Therapeutics Inc. Modification specifique de site de proteines a l'aide d'une modification chimique favorisant la formation de conjugues proteiques, la formation de dimeres proteiques et des peptides agrafes
WO2011110049A1 (fr) * 2010-03-12 2011-09-15 中国人民解放军军事医学科学院毒物药物研究所 Polypeptide de fusion anti-vih et son utilisation
WO2011127624A1 (fr) * 2010-04-13 2011-10-20 中国人民解放军军事医学科学院毒物药物研究所 Peptide anti-vih
CN102180951B (zh) * 2011-05-03 2012-09-26 中国医学科学院病原生物学研究所 胆固醇修饰的抗hiv多肽药物及其用途
JP6290187B2 (ja) 2012-05-11 2018-03-07 クランツ，アレクサンダー 癌の処置のためのタンパク質の部位特異的標識及び標的送達
SI3007717T1 (sl) * 2013-06-12 2018-12-31 Pharis Biotec Gmbh Peptidi z antagonističnimi aktivnostmi proti naravnemu CXCR4
JP7100639B2 (ja) * 2016-09-06 2022-07-13 メインライン バイオサエンシズ Ｃｘｃｒ４アンタゴニストおよび使用方法
JP2019535703A (ja) * 2016-11-09 2019-12-12 ファリス バイオテック ゲーエムベーハー プロトランスデューシン−ｃ：遺伝子導入活性化因子
CN114450324B (zh) * 2019-09-26 2024-02-27 日油株式会社 具有肽连接子的异双官能单分散聚乙二醇
JPWO2022202785A1 (fr) * 2021-03-22 2022-09-29

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1228203E (pt) * 1999-11-08 2008-09-03 Ipf Pharmaceuticals Gmbh Péptido inibidor de vírus circulante humano (virip) e a sua utilização
ATE519782T1 (de) * 2002-12-19 2011-08-15 Ipf Pharmaceuticals Gmbh Peptide und ihre verwendung zur behandlung von hiv infektionen

Also Published As

Publication number Publication date
BRPI0511005A (pt) 2007-11-20
CN1968964A (zh) 2007-05-23
AU2005254736B2 (en) 2011-08-18
US20070123465A1 (en) 2007-05-31
AP2081A (en) 2010-01-04
EA011037B1 (ru) 2008-12-30
MXPA06014393A (es) 2007-07-04
JP2008505854A (ja) 2008-02-28
WO2005123771A3 (fr) 2006-02-09
EP1756160A2 (fr) 2007-02-28
JP4782782B2 (ja) 2011-09-28
AU2005254736A1 (en) 2005-12-29
ZA200705769B (en) 2008-09-25
AP2007003877A0 (en) 2007-02-28
EA200700062A1 (ru) 2007-04-27
CA2569807A1 (fr) 2005-12-29
WO2005123771A2 (fr) 2005-12-29
EP1756160B1 (fr) 2013-08-14
CN100577686C (zh) 2010-01-06

Similar Documents

Publication Publication Date Title
NO20070296L (no) Oligomere peptider og deres anvendelse for behandling av HIV infeksjoner
WO2005123771B1 (fr) Peptides oligomeres et leur utilisation pour traiter des infections a vih
MXPA06001283A (es) Derivados de insulina novedosos.
EP2829549A3 (fr) Expression tandem et hybride de protéines de Neisserial
BRPI0606612A2 (pt) expressão recombinante de proteìnas em uma forma de duas cadeias ligadas por dissulfeto
AR064555A1 (es) Peptido wt1 restringido a hla-a*1101 y composicion farmaceutica que comprende el mismo
ATE517119T1 (de) Einzelketteninsulin
PH12012502372A1 (en) Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
ECSP066495A (es) Composiciones y metodos para inhibir la infección por virus de síndrome de punto blanco (wssv)
WO2006046239B1 (fr) Proteine specifique au thymus
MX2022002433A (es) Análogos de compstatina y sus usos médicos.
FR3078535B1 (fr) Composition vaccinale anti-pd-l1
EA201100459A1 (ru) Композиции, включающие интерлейкин-1 и пептиды
ATE280827T1 (de) Penaeidine: antimikrobielle peptide aus krebstieren
WO2004112820A3 (fr) Peptides et peptidomimetiques activite immunomodulatrice, anti-inflammatoire et antivirale
WO2006075253A3 (fr) Peptides destines a desensibiliser des sujets allergiques au poil de chien ou aux squames, et compositions contenant ces peptides
EP2333060A3 (fr) Peptides se liant au HLA, fragments d'ADN codant pour lesdits peptides et vecteurs recombinants
ATE411812T1 (de) Peptide zur behandlung von infektionen mit dem herpes-virus
EA200500533A1 (ru) Пептидные производные - ингибиторы слияния при вич-инфекции
WO2004056871A3 (fr) Peptides et leur utilisation pour le traitement d'infections par le vih
DE69117965D1 (de) Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper
WO2007002233A3 (fr) Analogues d'interferon-alpha humains a circulation longue et faible toxicite
SG170092A1 (en) Peptides of regulatory or accessory proteins of hiv, compositions and the utilization thereof
DK1425295T3 (da) Modificerede peptider og deres anvendelse til behandling af autoimmune sygdomme
Shimizu et al. Studies on aldolases I. Amino acid composition and subunit structure of rabbit-muscle aldolase

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application